Exploratory Research in Clinical and Social Pharmacy

Open accessIn DOAJFee waivers availableMedicine

Exploratory Research in Clinical and Social Pharmacy is published by Elsevier BV as an open access journal (ISSN 2667-2766). The list article processing charge is $2,140. Typical time to publication is 16 wks. Its OpenAlex h-index is 23. Primary field: Medicine. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$2,140

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

16 wks

Broadly typical for the field.

h-index

23

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

2.5

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Exploratory Research in Clinical and Social Pharmacy is listed at $2,140. The publisher also lists 2,000 EUR, 1,710 GBP, 265,420 JPY. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Exploratory Research in Clinical and Social Pharmacy, as recorded by OpenAlex for each year. The fee has risen 19% since 2021, from $1,800 to $2,140.

$0$1.1k$2.1k2021: $1,80020212022: $1,80020222023: $1,80020232024: $1,80020242025: $2,1402025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC, CC BY-NC-ND
Author keeps copyrightNo
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.Confirmed
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
  • Peer review model publicly declaredAnonymous peer reviewConfirmed
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Confirmed
  • Screens submissions for plagiarismReported to DOAJ by the journal.Confirmed
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Confirmed
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Confirmed
  • Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Exploratory Research in Clinical and Social Pharmacy publishes most, derived from the topics assigned to its indexed articles.

Pharmaceutical Practices and Patient OutcomesMedication Adherence and ComplianceAntibiotic Use and ResistancePatient Safety and Medication ErrorsPharmaceutical Economics and PolicyElectronic Health Records SystemsOpioid Use Disorder TreatmentMobile Health and mHealth ApplicationsPharmaceutical Quality and CounterfeitingCOVID-19 and Mental Health

Publication record

Indexed articles775
Total citations4,054
i10-index120
Most recent indexed article2026
Open access since2021
All ISSNs2667-2766

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.